Texas Retina Associates Breaks Ground on New Waco Area Office!
We’re excited to announce that on January 15, 2022, we broke ground on a new, larger Waco area office located at: 203 Archway Drive Woodway, Texas 76712 This new office, slated to
read more
Three Texas Retina Associates Physicians Earn Honor Awards at American Society of Retina Specialists 2021 Annual Meeting
The American Society of Retina Specialists (ASRS) named Deborah Y. Chong, MD, and Robert C. Wang, MD, “Honor Awardees” at the organization’s 2021 Annual Scientific Meeting held recently in San Antonio. They
read more
Texas Retina Associates Collaborates on Gene Therapy Research for Rare, Inherited Retina Condition
Texas Retina Associates and the Retina Foundation of the Southwest (RFSW) have been working in collaboration on new gene therapy treatments for inherited blinding diseases for which there are no cures. Most
read more
Seven Texas Retina Associates Physicians Earn New Professional Designation
The American Society of Retina Specialists has awarded its Fellow of the ASRS (FASRS) designation to the following Texas Retina Associates physicians: David Callanan, MD Rajiv Anand, MD Michel J. Shami, MD
read more
Texas Retina Associates Announces the Retirement of Dwain G. Fuller, MD
It is bittersweet that we announce the retirement of Dwain Fuller, M.D., from our practice effective December 31, 2020. He has been an integral part of Texas Retina Associates, caring for patients
read more
Texas Retina Associates Participating in New Phase II Clinical Trial for Choroidal Melanoma
Texas Retina Associates is pleased to announce its participation in a groundbreaking new Phase II clinical trial for the treatment of small choroidal (ocular) melanoma. Together with Aura Biosciences, we are investigating
read more
Texas Retina Associates Participating in Pagoda Clinical Trial for Diabetic Macular Edema
Sponsored by Genentech, the Pagoda clinical trial is studying an investigational drug delivery system for diabetic macular edema (DME) treatment to see if it could result in fewer eye injections and eye
read more
Texas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read more
Honoring the Life and Legacy of Texas Retina Associates Co-founder William B. Snyder, MD
One of the three founders of Texas Retina Associates, William B. Snyder, MD, passed away on January 18, 2019, at the age of 87. The child of two physicians, Dr. Snyder attended
read more
Texas Retina Associates Featured in Cover Story of Ophthalmic Professional Publication
Texas Retina Associates’ adoption of “better, stronger, faster” technologies, to enhance patient care and service is featured in the cover story of the latest issue of Ophthalmic Professional. The article highlights how
read more